1. World Health Organization (WHO) (2006), Second Global Consultation on Regulatory Requirements for Human Cells and Tissues for Transplantation: Towards Global Harmonization Through Graduated Standards, June 7–9; Geneva, Switzerland. Geneve. https://apps.who.int/iris/handle/10665/341776?locale-attribute=es&show=full Accessed 23 dec 2022.
2. World Health Organization (WHO), Model Lists of Essential Medicines. https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2021.02. Accessed 23 dec 2022.
3. World Health Organization (WHO), Sixty-third World Health Assembly: Availability, Safety and Quality of Blood Products. https://apps.who.int/iris/handle/10665/3086. Accessed 23 dec 2022.
4. Burnouf T. (2019). Blood products: unmet needs for essential medicines. Lancet Haematol: e598–9. doi:https://doi.org/10.1016/S2352-3026(19)30217-0. Accessed 23 dec 2022.
5. Brasil, Agência Nacional de Vigilância Sanitária. Estabelecimentos de Sangue, Tecidos e Células. Portal Anvisa. https://www.gov.br/anvisa/pt-br/assuntos/sangue/estabelecimentos-sangue-tecidos-celulas. Accessed 23 dec 2022.